Genetic Deletion or Pharmacological Inhibition of Cyclooxygenase-2 Reduces Blood-Brain Barrier Damage in Experimental Ischemic Stroke

Cyclooxygenase (COX)-2 and matrix metalloproteinase (MMP)-9 are two crucial mediators contributing to blood-brain barrier (BBB) damage during cerebral ischemia. However, it is not known whether MMP-9 activation is involved in COX-2-mediated BBB disruption in ischemic stroke. In this study, we hypoth...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Changjun, Yang, Yi, DeMars, Kelly M., Rosenberg, Gary A., Candelario-Jalil, Eduardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468510/
https://www.ncbi.nlm.nih.gov/pubmed/32973660
http://dx.doi.org/10.3389/fneur.2020.00887

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468510/
https://www.ncbi.nlm.nih.gov/pubmed/32973660
http://dx.doi.org/10.3389/fneur.2020.00887

Ejemplares similares